Barely Significant
← all excerpts

Mucinous, endometrioid, and serous ovarian cancers with peritoneal dissemination are potent candidates for P-cadherin targeted therapy: a retrospective cohort study.

BMC Cancer · 2021 · PMC7791827 · PMID 33413178

Europe PMCDOI
1
hedged sentence
0.0580
closest p · 1.2× alpha
0.0580
boldest claim

The sentences

showed a trendP = .058so close (0.05 < p ≤ 0.1)
As assessed by Kaplan-Meier survival analysis, patients with high expression of P-cadherin, although not significant, showed a trend toward a negative survival probability, as indicated by disease-free survival (DFS) and overall survival (OS) ( P = .058, Fig. 2 a; P = .050, Fig. 2 b).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.